Number One Provider of Pharmaceutical Development Services Establishes Strong API Presence in U.S. Patheon , a leading global provider of high-quality drug development and delivery solutions to the ...

Number One Provider of Pharmaceutical Development Services to Establish Global Solubility Center of Excellence in Western United States DURHAM, NC--(Marketwired - March 09, 2015) - Patheon, a leading ...

PARSIPPANY, N.J.-- Pacira Pharmaceuticals, Inc.(NASDAQ:PCRX) today announced entering into a strategic co-production partnership with Patheon, the pharmaceutical services business owned by DPx ...

DURHAM, N.C.--(BUSINESS WIRE)--Patheon N.V. (NYSE: PTHN), a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical sector, today announced that it ...

The king of life science acquisitions has struck again. Thermo Fisher Scientific announced Monday plans to acquire Patheon, a Durham, North Carolina-based contract development and manufacturing ...

DURHAM, N.C.--(BUSINESS WIRE)--Patheon N.V (NYSE: PTHN), a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, announced that ...

Durham-based Patheon N.V., a global provider of pharmaceutical development and manufacturing services that has a large production facility in Greenville, will be acquired by Thermo Fisher Scientific ...

TORONTO, Jan. 25, 2012 /PRNewswire via COMTEX/ -- Previously Senior Vice President and Managing Director European Operations, Mancuso now oversees Patheon's global commercial manufacturing platform ...

Two months after its $7.2 billion acquisition by Thermo Fisher was announced, Patheon says it is investing $45 million to expand operations at several sites, some recently acquired, in the U.S. and ...

TORONTO, Nov. 19, 2013 /CNW/ – Patheon Inc. (TSX:PTI) (“Patheon”) today announced that it has entered into an arrangement agreement (the “Arrangement Agreement”) with JLL/Delta Patheon Holdings, L.P., ...

Says believes Lonza bid in the best interests of co Says JLL cannot unilaterally dictate future of Patheon Welcomes expiry of JLL's $2-a-share bid TORONTO, Aug 28 (Reuters) - Canadian drug ...

Bend pharmaceutical company Patheon will invest in the city after its tax break was extended. The firm aims to hire 22 and invest $5.7 million. The City Council voted unanimously Dec. 16 to extend the ...